Skin permeation and penetration of crisaborole when coapplied with emollients - 09/11/20
Graphical abstract |
Funding: Sponsored by Pfizer Inc. Editorial/medical writing support under the guidance of the authors was provided by Robert J. Schoen, PharmD, Carole Greene, PhD, and Jennifer C. Jaworski, MS, at ApotheCom, San Francisco, California (funded by Pfizer Inc, New York, New York, in accordance with Good Publication Practice guidelines [Ann Intern Med. 2015;163:461-4]). |
|
Disclosure: Dr Draelos has received grants from Anacor Pharmaceuticals, Inc, to study crisaborole and has done consulting for Pfizer Inc. Dr Ports, Ms Vlahos, and Drs Yeoh, Wu-Linhares, and Thombre are employees of Pfizer Inc. Drs Brown and Lenn are employees of MedPharm Ltd, which received financial compensation from Pfizer to perform this study. |
|
IRB approval status: Not applicable. |
|
Reprints not available from the authors. |
Vol 83 - N° 6
P. 1801-1803 - décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?